French Guiana Wellness Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French Guiana Wellness Network.

Press releases published on May 6, 2026

Medline Reports First Quarter 2026 Results
Immusoft to Present Data Highlighting Positive Results from the World’s First Engineered B Cell in a Human Clinical Trial at ASGCT 2026
Altimmune to Report First Quarter 2026 Financial Results and Provide Business Update on May 13, 2026
BriaCell Receives FDA Clearance to Initiate Bria-BRES+™ Clinical Study in Breast Cancer
Crescent Biopharma to Present at May Investor Conferences
Lifecore Biomedical Reports Financial Results for the First Quarter Ended March 31, 2026, and Provides Corporate Update
Immunocore reports first quarter financial results and provides a business update
Kymera Therapeutics to Participate in Upcoming May Investor Conferences
Relmada Therapeutics to Report First Quarter 2026 Financial Results on Tuesday, May 12, 2026
Aquestive Therapeutics to Report First Quarter 2026 Financial Results and Recent Business Highlights on May 13 and Host Conference Call on May 14 at 8:00 a.m. ET
Kamada to Announce First Quarter 2026 Financial Results on May 13, 2026
TScan Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
EyePoint Reports First Quarter 2026 Financial Results and Highlights Recent Corporate Developments
BioCryst Reports First Quarter 2026 Financial Results and Provides Business Update
Geron Corporation Reports First Quarter 2026 Financial Results and Recent Business Highlights
Madrigal Pharmaceuticals Reports First-Quarter 2026 Financial Results and Provides Corporate Updates
Tonix Pharmaceuticals Secures Commercial Payer Coverage for TONMYA®, Providing Access for ~35 Million U.S. Patients
Tempest Presents Clinical Update at ISCT 2026 Annual Meeting
Anavex Life Sciences Board of Directors Appoints Former Senior Vice President of Clinical Development Terrie Kellmeyer, PhD, as Interim Chief Executive Officer
Eupraxia Pharmaceuticals’ First Release of EoEHSS Sub Scores Data from its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis at Digestive Disease Week

Share this page:

Sign up for:

French Guiana Wellness Network

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.